Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$0.2 - $0.36 $1,671 - $3,009
-8,359 Reduced 7.81%
98,728 $19,000
Q2 2022

Aug 08, 2022

BUY
$0.28 - $0.65 $438 - $1,017
1,565 Added 1.48%
107,087 $38,000
Q1 2022

May 12, 2022

SELL
$0.56 - $0.83 $3,808 - $5,644
-6,800 Reduced 6.05%
105,522 $66,000
Q4 2021

Feb 02, 2022

BUY
$0.67 - $1.32 $28,186 - $55,532
42,070 Added 59.88%
112,322 $86,000
Q3 2021

Nov 12, 2021

SELL
$1.02 - $1.83 $40,790 - $73,183
-39,991 Reduced 36.28%
70,252 $93,000
Q2 2021

Aug 03, 2021

BUY
$0.79 - $1.34 $12,284 - $20,837
15,550 Added 16.42%
110,243 $127,000
Q1 2021

May 10, 2021

BUY
$0.66 - $1.4 $62,497 - $132,570
94,693 New
94,693 $94,000
Q4 2018

Jan 29, 2019

SELL
$0.36 - $1.0 $13,128 - $36,469
-36,469 Closed
0 $0
Q3 2018

Oct 26, 2018

SELL
$0.89 - $1.28 $4,260 - $6,127
-4,787 Reduced 11.6%
36,469 $39,000
Q2 2018

Aug 10, 2018

BUY
$1.22 - $1.79 $50,332 - $73,848
41,256 New
41,256 $52,000

Others Institutions Holding CFMS

About Conformis Inc


  • Ticker CFMS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 187,856,992
  • Description
  • Conformis, Inc., a medical technology company, develops, manufactures, and sells patient-specific products and instrumentation. The company offers personalized knee replacement products, including iUni, iDuo, a custom-made partial knee replacement option for either unicompartmental or bicompartmental osteoarthritis of the knee; iTotal CR, a cruc...
More about CFMS
Track This Portfolio

Track Oppenheimer & CO Inc Portfolio

Follow Oppenheimer & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer & CO Inc with notifications on news.